Testing effectiveness (Phase 2)Ended earlyNCT04788459
What this trial is testing
Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers
Who this might be right for
COVID-19Protection Against COVID-19 and Infections With SARS-CoV- 2COVID-19 Immunisation
Takis 68